University Health Industries Announces New Name and Ticker Symbol

Share Article

University Health Industries, Inc., (OTC:UVHI) a Florida corporation engaged in the development, marketing and sale of proprietary, patent-pending nutraceutical products, including its leading brands Arthroleve(TM) and Zenstral PMS(TM), announces new name and ticker symbol.

    University Health Industries, Inc., announces that effective at the open of business today, its new ticker symbol will be "UVHI" (Pink Sheets) replacing the former ticker symbol "VRTN" (Pink Sheets). This ticker symbol change corresponds with the corporate name change to University Health Industries, Inc., formerly Virtual Innovations, Inc.

About University Health Industries:

( Every year university labs around the globe identify research and test natural compounds and formulations which have the potential to improve our quality of life. The majority of these potentially life changing discoveries are never commercialized for the benefit of the public.

University Health Industries, in collaboration with university based researchers worldwide, researches and identifies those compounds that have proven evidence based effects and have the greatest potential for improving our lives.

University Health Industries' mission is to deliver the latest advances and discoveries in natural compounds packaged in our unique patented formulations including Arthroleve(TM) ( as well as Zenstral PMS(TM) ( and delivered to satisfy the needs of consumers for the promotion of health for many common age-related health concerns.

Safe Harbor Forward-Looking Statements:

Except for historical matters contained herein, the matters discussed in this press release are "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that these forward-looking statements reflect numerous assumptions and involve risks and uncertainties that may affect University Health Industries, Inc. and its subsidiary businesses (collectively, the "Company") and prospects and cause actual results to differ materially from these forward-looking statements.

Keyword Tags: arthritis, arthritis treatment, arthroleve, pms, university health industries, zenstral pms

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Dr. Jarret Morrow
Visit website